Chemoinformaics analysis of Heptanal
Molecular Weight | 114.188 | nRot | 5 |
Heavy Atom Molecular Weight | 100.076 | nRig | 24 |
Exact Molecular Weight | 114.104 | nRing | 0 |
Solubility: LogS | -2.557 | nHRing | 0 |
Solubility: LogP | 2.74 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 21.8271 |
nHD | 0 | BPOL | 14.9129 |
QED | 0.828 |
Synth | 3.268 |
Natural Product Likeliness | 1.497 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.199 |
Pgp-sub | 0.356 |
HIA | 0.002 |
CACO-2 | -4.676 |
MDCK | 0.0000301 |
BBB | 0.943 |
PPB | 0.874208 |
VDSS | 1.86 |
FU | 0.0764561 |
CYP1A2-inh | 0.267 |
CYP1A2-sub | 0.974 |
CYP2c19-inh | 0.114 |
CYP2c19-sub | 0.948 |
CYP2c9-inh | 0.012 |
CYP2c9-sub | 0.859 |
CYP2d6-inh | 0.232 |
CYP2d6-sub | 0.93 |
CYP3a4-inh | 0.535 |
CYP3a4-sub | 0.929 |
CL | 9.497 |
T12 | 0.265 |
hERG | 0.505 |
Ames | 0.268 |
ROA | 0.656 |
SkinSen | 0.098 |
Carcinogencity | 0.179 |
EI | 0.008 |
Respiratory | 0.939 |
NR-Aromatase | 0.31 |
Antiviral | No |
Prediction | 0.95414 |